Display options
Share it on

Front Bioeng Biotechnol. 2020 Aug 07;8:936. doi: 10.3389/fbioe.2020.00936. eCollection 2020.

A Systematic Approach to Review of .

Frontiers in bioengineering and biotechnology

Mike Bracher, Geoffrey J Pilkington, C Oliver Hanemann, Karen Pilkington

Affiliations

  1. School of Health Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
  2. School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom.
  3. Institute of Translational and Stratified Medicine, University of Plymouth, Plymouth, United Kingdom.
  4. School of Health and Social Care Professions, University of Portsmouth, Portsmouth, United Kingdom.

PMID: 32850761 PMCID: PMC7427312 DOI: 10.3389/fbioe.2020.00936

Abstract

BACKGROUND: A wide range of human

OBJECTIVES: To identify criteria for evaluation of quality and human relevance of

METHODS: Stage one involved identification of potential criteria for evaluation of

RESULTS: Results of stage one indicated that methods for and quality of review of

CONCLUSION: Through a systematic process of collating assessment criteria and subjecting these to expert review, SAToRI-BTR has resulted in preliminary guidance for appraisal of

Copyright © 2020 Bracher, Pilkington, Hanemann and Pilkington.

Keywords: brain tumour; cancer; critical appraisal; evaluation; in vitro; quality appraisal; systematic review

References

  1. Br J Cancer. 2000 May;82(9):1495-509 - PubMed
  2. PLoS Med. 2009 Jul 21;6(7):e1000097 - PubMed
  3. Toxicol In Vitro. 2017 Dec;45(Pt 3):272-277 - PubMed
  4. Br J Gen Pract. 2007 Dec;57(545):971-8 - PubMed
  5. PLoS Biol. 2010 Jun 29;8(6):e1000412 - PubMed
  6. Toxicol Lett. 2009 Sep 10;189(2):138-44 - PubMed
  7. Arch Toxicol. 2017 Jan;91(1):1-33 - PubMed
  8. J Oral Sci. 2010 Mar;52(1):1-11 - PubMed
  9. Curr Med Res Opin. 2019 Sep;35(9):1631-1641 - PubMed
  10. Br J Cancer. 2005 Aug 22;93(4):387-91 - PubMed
  11. Implement Sci. 2017 Mar 4;12(1):30 - PubMed
  12. PLoS One. 2011;6(6):e20476 - PubMed
  13. Appl In Vitro Toxicol. 2018 Dec 1;4(4):305-316 - PubMed
  14. ALTEX. 2019;36(1):3-17 - PubMed
  15. BMJ. 2011 Oct 18;343:d5928 - PubMed
  16. JAMA. 1998 May 13;279(18):1489-91 - PubMed
  17. PLoS One. 2016 Jul 26;11(7):e0159860 - PubMed
  18. Nat Genet. 2001 Dec;29(4):365-71 - PubMed
  19. Regul Toxicol Pharmacol. 1997 Feb;25(1):1-5 - PubMed
  20. PLoS Med. 2012;9(5):e1001216 - PubMed
  21. Nat Biotechnol. 2008 Aug;26(8):889-96 - PubMed
  22. Altern Lab Anim. 2002 Jul-Aug;30(4):407-14 - PubMed
  23. ALTEX. 2017;34(1):95-132 - PubMed
  24. Am J Nephrol. 2011;33(6):558-66 - PubMed
  25. Soc Sci Med. 2016 May;156:90-7 - PubMed
  26. Regul Toxicol Pharmacol. 2016 Apr;76:187-98 - PubMed
  27. Genome Biol. 2015 Jul 23;16:141 - PubMed
  28. Br J Cancer. 2014 Sep 9;111(6):1021-46 - PubMed

Publication Types